drugset / Trial / NCT01768676
Study Evaluating the Effects of Avanafil on Semen Parameters
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to determine whether avanafil will affect different aspects of sperm production.
Timeline
- Start
- 2012-12
- Primary completion
- 2014-08
- Completion
- 2014-08
Outcome
Met primary endpoint
registry analysis (non-inferiority or equivalence test); Avanafil vs Placebo; Risk Difference (RD) -12.93 (95% CI -21.56 to -4.29) NCT01768676 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Avanafil | Small molecule | 100 mg | — |